Altimmune’s pemvidutide shows promising Phase IIb MASH results; see key benefits, risks, and a bullish outlook. Read here for ...
More than 140,000 bottles of a popular drug commonly prescribed to reduce cholesterol have been recalled for a defect that ...
McCormick said in a press conference Thursday that he was concerned nitazenes “would become the next fentanyl,” the opioid behind a massive rise in overdose deaths across the U.S.
Insider claims people have found a way to get around the move BOSSES of the new Harry Potter TV series have hired sniffer dogs over fears of drugs being used on set. They suspect trades-people working ...
Researchers from Queen Mary University of London's School of Biological and Behavioral Sciences, using the simple fission yeast as a model, have shown that the new TOR inhibitor rapalink-1 prolongs ...
The new class of anti-obesity drugs, glucagon-like peptide-1 receptor agonists (GLP-1RAs), is proving remarkably effective at helping individuals lose weight. However, a new population-wide study ...
Zepbound (tirzepatide) and Ozempic (semaglutide) are brand-name subcutaneous injections. They’re both prescribed for weight loss and weight management, but only Zepbound has been FDA-approved for this ...
There is no biological measure for wakefulness. In a narcolepsy clinical trial, a patient lies down in a dark lab while clinicians count the minutes until sleep comes. The average time in four tests ...
Many middle-class American families are eager for relief from high prescription drug costs, and President Donald Trump’s executive order has raised hopes for change. Read More: Mark Cuban Says Trump’s ...
Q. Why isn’t Singulair (montelukast) available over the counter? It has a better safety profile than antihistamines and is safe in children. How does one advocate for a generic drug to change its ...
MONTREAL — Lawyers involved in a class-action lawsuit over the drug Rexulti say a $4.75 million settlement has been reached on behalf of patients and the estates and families of those who were ...